Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells.
This investigation was undertaken to determine prolonged adverse effects of benzalkonium chloride (BzCl), a cationic surfactant, and sodium dodecyl sulfate (SDS), an anionic surfactant, after an initial treatment of and subsequent removal from a primary culture system of rabbit corneal epithelial cells. Metabolic integrity and cell growth were evaluated at specified periods after a 1-hr treatment with the surfactants because of their importance in tissue repair. Intracellular calcium ([Ca2+]i) and intracellular pH (pHi) were also measured because of their importance in cellular homeostasis. ATP/ADP ratios were used to assess metabolic integrity, and propidium iodide staining of cells was used to measure relative cell number and cell growth. Digitized fluorescence imaging was used to measure [Ca2+]i with fura-PE3 and pHi with 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF). BzCl induced a concentration-dependent decrease in ATP/ADP ratios 24 hr after its removal from the cultures, whereas SDS had minimal effects on metabolic integrity throughout the 48-hr postexposure measurement period. The proliferative response of cultures treated with SDS, however, was decreased when compared with BzCl-treated cells. BzCl induced an increase in [Ca2+]i, whereas SDS decreased [Ca2+]i 1-3 hr after removal of surfactants. BzCl produced a sustained decrease in pHi in surviving cells 1-4 hr after its removal, with a return to control values at 24-48 hr. SDS transiently increased pHi 1 hr after its removal and decreased pHi at the 48-hr post-treatment period. In conclusion, the two surfactants in vitro had distinctly different prolonged effects on corneal epithelial cells, which may suggest that BzCl and SDS differentially affect cellular recovery in vivo.
Grant
R L
RL
Division of Pharmacology and Toxicology, University of Texas, Austin, Texas, 78712-1074, USA.
Acosta
D
D
D000244:Adenosine Diphosphate / Q000032:analysis; D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D001548:Benzalkonium Compounds / Q000633:toxicity*; D002118:Calcium / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D003315:Cornea / Q000166:cytology / Q000187:drug effects* / Q000473:pathology; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D005123:Eye / Q000187:drug effects; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D006868:Hydrolysis / Q000187:drug effects; D007089:Image Enhancement; D008297:Male; D008856:Microscopy, Fluorescence; D011817:Rabbits; D012967:Sodium Dodecyl Sulfate / Q000633:toxicity*; D013501:Surface-Active Agents / Q000633:toxicity*
D001548:Benzalkonium Compounds; D013501:Surface-Active Agents; D012967:Sodium Dodecyl Sulfate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D002118:Calcium